Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes

Citations

WEB OF SCIENCE

18
Citations

SCOPUS

17

초록

Objective: We investigated (1) the associations between pre-stroke aspirin use and thrombus burden, infarct volume, hemorrhagic transformation, early neurological deterioration (END), and functional outcome, and (2) whether stroke subtypes modify these associations in first-ever ischemic stroke. Methods: This multicenter magnetic resonance imaging (MRI)-based study included 5,700 consecutive patients with acute first-ever ischemic stroke, who did not undergo intravenous thrombolysis or endovascular thrombectomy, from May 2011 through February 2014. Propensity score-based augmented inverse probability weighting was performed to estimate adjusted effects of pre-stroke aspirin use. Results: The mean age was 67 years (41% women), and 15.9% (n = 907) were taking aspirin before stroke. Pre-stroke aspirin use (vs nonuse) was significantly related to a reduced infarct volume (by 30%), particularly in large artery atherosclerosis stroke (by 45%). In cardioembolic stroke, pre-stroke aspirin use was associated with a similar to 50% lower incidence of END (adjusted difference = -5.4%, 95% confidence interval [CI] = -8.9 to -1.9). Thus, pre-stroke aspirin use was associated with similar to 30% higher likelihood of favorable outcome (3-month modified Rankin Scale score < 3), particularly in large artery atherosclerosis stroke and cardioembolic stroke (adjusted difference = 7.2%, 95% CI = 1.8 to 12.5 and adjusted difference = 6.4%, 95% CI = 1.7 to 11.1, respectively). Pre-stroke aspirin use (vs nonuse) was associated with 85% less frequent cerebral thrombus-related susceptibility vessel sign (SVS) in large artery atherosclerosis stroke (adjusted difference = -1.4%, 95% CI = -2.1 to -0.8, p < 0.001) and was associated with similar to 40% lower SVS volumes, particularly in cardioembolic stroke (adjusted difference = -0.16 cm(3), 95% CI = -0.29 to -0.02, p = 0.03). Moreover, pre-stroke aspirin use was not significantly associated with hemorrhagic transformation (adjusted difference = -1.1%, p = 0.09). Interpretation :Pre-stroke aspirin use associates with improved functional independence in patients with first-ever ischemic large arterial stroke by reducing infarct volume and/or END, likely by decreasing thrombus burden, without increased risk of hemorrhagic transformation.

키워드

ACUTE ISCHEMIC-STROKEHEMORRHAGIC TRANSFORMATIONSEVERITYTHROMBECTOMYLEUKOARAIOSISSUSCEPTIBILITYRESISTANCEREGISTRYSUBTYPEGROWTH
제목
Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes
저자
Ryu, Wi-SunSchellingerhout, DawidHong, Keun-SikJeong, Sang-WukKim, Beom JoonKim, Joon-TaeLee, Kyung BokPark, Tai HwanPark, Sang-SoonPark, Jong-MooKang, KyusikCho, Yong-JinPark, Hong-KyunLee, Byung-ChulYu, Kyung-HoOh, Mi SunLee, Soo JooKim, Jae GukCha, Jae-KwanKim, Dae-HyunLee, JunHan, Moon-KuPark, Man SeokChoi, Kang-HoNahrendorf, MatthiasLee, JuneyoungBae, Hee-JoonKim, Dong-Eog
DOI
10.1002/ana.26219
발행일
2021-11
유형
Article
저널명
Annals of Neurology
90
5
페이지
763 ~ 776